Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 10185

BillFederalHouseIn Committee
To require the Secretary of Health and Human Services to establish a temporary premium credit for enrollees in prescription drug plans under the Medicare program.
About This Bill
Committee
Latest Action · August 31, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced
August 31, 2026
Cosponsors (0)
None
View PDF ↗
SummaryFull TextCommentsAnnotations

Summary

Highlight any text to annotate
This bill would create a temporary premium discount for Medicare beneficiaries enrolled in prescription drug plans (Part D) during 2027. The discount amount would be based on average premium reductions seen in a previous Medicare demonstration program that ran from 2025 through 2026. The Health and Human Services Secretary would calculate the credit based on actual premium data and then require drug plan sponsors to reduce what they charge enrollees by that amount, with the federal government reimbursing the sponsors for the difference. The legislation affects millions of Medicare beneficiaries who use Part D drug plans, though no specific funding amount is specified in the bill text itself. The credit is described as temporary and would apply only to 2027 enrollment.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.